ABL1	2	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	
ACAN	4	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	2_CELL_CYCLE_GO_0007049	0.750	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_MELANOMA	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	
ACTB	4	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	2_CELL_CYCLE_GO_0007049	1.000	0_HALLMARK_MYC_TARGETS_V1	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	2_CELL_CYCLE_PROCESS	0.750	2_DNA_REPLICATION	0.750	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	
ACTN1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_CELL_CYCLE_GO_0007049	1.000	1_KEGG_P53_SIGNALING_PATHWAY	0.500	
ACVRL1	1	
ADAM12	7	0_HALLMARK_E2F_TARGETS	0.857	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.857	1_KEGG_CELL_CYCLE	0.857	1_KEGG_P53_SIGNALING_PATHWAY	0.857	1_KEGG_FOCAL_ADHESION	0.857	1_KEGG_PATHWAYS_IN_CANCER	0.714	2_NON_MEMBRANE_BOUND_ORGANELLE	0.714	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.714	2_CELL_CYCLE_GO_0007049	0.714	2_REGULATION_OF_CELL_CYCLE	0.714	
ADCY2	2	
ADCY5	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	
ADCY6	1	
ADCY8	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	
ADCY9	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_COAGULATION	0.500	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_VASCULAR_SMOOTH_MUSCLE_CONTRACTION	0.500	1_KEGG_FOCAL_ADHESION	0.500	
ADCYAP1R1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	2_AXON	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_NEURON_PROJECTION	1.000	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
AHR	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	
AKAP6	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	2_CELL_CELL_SIGNALING	0.333	2_SYNAPTIC_TRANSMISSION	0.333	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.333	2_TRANSMISSION_OF_NERVE_IMPULSE	0.333	2_GLUTAMATE_RECEPTOR_ACTIVITY	0.333	2_GABA_RECEPTOR_ACTIVITY	0.333	2_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY	0.333	
AKAP9	8	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.375	1_KEGG_FOCAL_ADHESION	0.375	1_KEGG_ECM_RECEPTOR_INTERACTION	0.375	2_CELL_CYCLE_GO_0007049	0.375	2_GABA_RECEPTOR_ACTIVITY	0.375	0_HALLMARK_APOPTOSIS	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	
AKT1	4	1_KEGG_MELANOMA	0.750	2_CELL_CELL_SIGNALING	0.750	2_SYNAPTIC_TRANSMISSION	0.750	2_TRANSMISSION_OF_NERVE_IMPULSE	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_COLLAGEN	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	
AKT3	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APICAL_JUNCTION	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_DNA_REPLICATION	0.500	
AMPH	7	0_HALLMARK_E2F_TARGETS	0.714	1_KEGG_CELL_CYCLE	0.714	0_HALLMARK_G2M_CHECKPOINT	0.571	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.571	2_CELL_CYCLE_GO_0007049	0.571	2_REGULATION_OF_CELL_CYCLE	0.571	2_GABA_RECEPTOR_ACTIVITY	0.571	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.429	0_HALLMARK_MYC_TARGETS_V1	0.429	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.429	
ANAPC1	2	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	
ANAPC7	1	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	1.000	1_KEGG_OOCYTE_MEIOSIS	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	2_RECEPTOR_ACTIVITY	1.000	
ANK1	8	2_GABA_RECEPTOR_ACTIVITY	0.375	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_APOPTOSIS	0.250	0_HALLMARK_COMPLEMENT	0.250	0_HALLMARK_E2F_TARGETS	0.250	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.250	0_HALLMARK_UV_RESPONSE_DN	0.250	0_HALLMARK_COAGULATION	0.250	1_KEGG_CELL_CYCLE	0.250	1_KEGG_P53_SIGNALING_PATHWAY	0.250	
ANK2	10	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	2_EXTRACELLULAR_MATRIX_PART	0.700	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.600	2_EXTRACELLULAR_MATRIX	0.600	2_COLLAGEN	0.600	2_GABA_RECEPTOR_ACTIVITY	0.600	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_CELL_CYCLE	0.500	
ANK3	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_OOCYTE_MEIOSIS	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_GLIOMA	0.500	
APEX2	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	2_CELL_CYCLE_GO_0007049	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_BASE_EXCISION_REPAIR	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_FOCAL_ADHESION	0.333	
APOB	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.750	2_EXTRACELLULAR_MATRIX_PART	0.750	2_EXTRACELLULAR_MATRIX	0.750	2_COLLAGEN	0.750	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	0.500	
ASPM	4	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	2_NON_MEMBRANE_BOUND_ORGANELLE	0.750	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.750	2_CELL_CYCLE_GO_0007049	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	1_KEGG_MELANOMA	0.500	2_REPLICATION_FORK	0.500	
ATM	6	0_HALLMARK_E2F_TARGETS	0.833	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.833	1_KEGG_CELL_CYCLE	0.833	1_KEGG_P53_SIGNALING_PATHWAY	0.833	1_KEGG_FOCAL_ADHESION	0.833	2_CELL_CYCLE_GO_0007049	0.833	2_REGULATION_OF_CELL_CYCLE	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_UV_RESPONSE_DN	0.500	
ATN1	4	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.750	2_GABA_RECEPTOR_ACTIVITY	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	
ATR	6	0_HALLMARK_E2F_TARGETS	0.833	1_KEGG_CELL_CYCLE	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	2_CELL_CYCLE_GO_0007049	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	
ATRX	12	0_HALLMARK_E2F_TARGETS	0.833	1_KEGG_CELL_CYCLE	0.833	0_HALLMARK_G2M_CHECKPOINT	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	2_CELL_CYCLE_GO_0007049	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.583	2_CHROMOSOME	0.583	2_CELL_CYCLE_PROCESS	0.583	2_MITOTIC_CELL_CYCLE	0.583	2_CELL_CYCLE_PHASE	0.583	
B2M	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	
BARD1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	0_HALLMARK_MITOTIC_SPINDLE	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_COMPLEMENT	0.500	
BCAR1	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
BCLAF1	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_KRAS_SIGNALING_UP	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	
BCR	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_BLADDER_CANCER	1.000	1_KEGG_GLIOMA	0.667	
BLM	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	
BMPR1B	1	
BRCA1	4	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_FOCAL_ADHESION	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	
BSG	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	1_KEGG_P53_SIGNALING_PATHWAY	0.500	
BTRC	5	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_CELL_CYCLE	0.800	1_KEGG_P53_SIGNALING_PATHWAY	0.800	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	1_KEGG_BLADDER_CANCER	0.800	2_CELL_CYCLE_GO_0007049	0.800	
BUB3	7	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.857	1_KEGG_P53_SIGNALING_PATHWAY	0.857	1_KEGG_FOCAL_ADHESION	0.857	1_KEGG_ECM_RECEPTOR_INTERACTION	0.714	1_KEGG_PATHWAYS_IN_CANCER	0.714	2_NON_MEMBRANE_BOUND_ORGANELLE	0.714	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.714	
CACNA1B	5	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.400	2_CALCIUM_CHANNEL_ACTIVITY	0.400	0_HALLMARK_G2M_CHECKPOINT	0.200	0_HALLMARK_E2F_TARGETS	0.200	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.200	0_HALLMARK_UV_RESPONSE_DN	0.200	0_HALLMARK_ANGIOGENESIS	0.200	1_KEGG_CELL_CYCLE	0.200	1_KEGG_P53_SIGNALING_PATHWAY	0.200	1_KEGG_FOCAL_ADHESION	0.200	
CACNA1C	4	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.500	2_CALCIUM_CHANNEL_ACTIVITY	0.500	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.250	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.250	0_HALLMARK_UV_RESPONSE_DN	0.250	0_HALLMARK_ANGIOGENESIS	0.250	1_KEGG_FOCAL_ADHESION	0.250	1_KEGG_ECM_RECEPTOR_INTERACTION	0.250	1_KEGG_TYPE_II_DIABETES_MELLITUS	0.250	1_KEGG_PANCREATIC_CANCER	0.250	
CACNA1E	5	2_CALCIUM_CHANNEL_ACTIVITY	0.800	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.400	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.400	2_CATION_CHANNEL_ACTIVITY	0.400	2_GATED_CHANNEL_ACTIVITY	0.400	2_SUBSTRATE_SPECIFIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.400	2_SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY	0.400	2_SUBSTRATE_SPECIFIC_TRANSPORTER_ACTIVITY	0.400	2_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.400	2_ION_CHANNEL_ACTIVITY	0.400	
CACNA1G	1	1_KEGG_CALCIUM_SIGNALING_PATHWAY	1.000	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	1.000	2_CATION_CHANNEL_ACTIVITY	1.000	2_GATED_CHANNEL_ACTIVITY	1.000	2_SUBSTRATE_SPECIFIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	1.000	2_SUBSTRATE_SPECIFIC_CHANNEL_ACTIVITY	1.000	2_SUBSTRATE_SPECIFIC_TRANSPORTER_ACTIVITY	1.000	2_CALCIUM_CHANNEL_ACTIVITY	1.000	2_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	1.000	2_ION_CHANNEL_ACTIVITY	1.000	
CACNA1H	9	2_REGULATION_OF_HEART_CONTRACTION	0.778	2_CALCIUM_CHANNEL_ACTIVITY	0.444	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.111	0_HALLMARK_COMPLEMENT	0.111	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.111	0_HALLMARK_UV_RESPONSE_DN	0.111	1_KEGG_FOCAL_ADHESION	0.111	1_KEGG_ECM_RECEPTOR_INTERACTION	0.111	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.111	
CACNA1I	4	2_CELL_CELL_SIGNALING	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.250	1_KEGG_CELL_CYCLE	0.250	1_KEGG_PATHWAYS_IN_CANCER	0.250	1_KEGG_MELANOMA	0.250	2_REGULATION_OF_PHOSPHORYLATION	0.250	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.250	2_SYNAPTIC_TRANSMISSION	0.250	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.250	
CACNA1S	7	0_HALLMARK_E2F_TARGETS	0.429	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.429	1_KEGG_CELL_CYCLE	0.429	1_KEGG_FOCAL_ADHESION	0.429	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.429	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.429	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.429	1_KEGG_ASTHMA	0.429	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.429	1_KEGG_ALLOGRAFT_REJECTION	0.429	
CACNB3	1	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	1.000	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_INFLAMMATORY_RESPONSE	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	
CALM1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	
CALML5	5	0_HALLMARK_G2M_CHECKPOINT	0.400	0_HALLMARK_E2F_TARGETS	0.400	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.400	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.400	1_KEGG_CELL_CYCLE	0.400	1_KEGG_OOCYTE_MEIOSIS	0.400	1_KEGG_P53_SIGNALING_PATHWAY	0.400	1_KEGG_FOCAL_ADHESION	0.400	1_KEGG_ECM_RECEPTOR_INTERACTION	0.400	1_KEGG_PATHWAYS_IN_CANCER	0.400	
CBL	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	
CBLB	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	
CCL3L1	1	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_COAGULATION	1.000	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	1.000	2_INFLAMMATORY_RESPONSE	1.000	2_RESPONSE_TO_STRESS	1.000	2_RESPONSE_TO_EXTERNAL_STIMULUS	1.000	2_RESPONSE_TO_WOUNDING	1.000	
CCNF	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	
CCT2	8	0_HALLMARK_E2F_TARGETS	0.375	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.375	1_KEGG_CELL_CYCLE	0.375	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.375	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.375	1_KEGG_LEISHMANIA_INFECTION	0.375	1_KEGG_ASTHMA	0.375	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.375	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.375	1_KEGG_ALLOGRAFT_REJECTION	0.375	
CCT6A	19	2_KINESIN_COMPLEX	0.263	0_HALLMARK_G2M_CHECKPOINT	0.211	0_HALLMARK_E2F_TARGETS	0.211	1_KEGG_CELL_CYCLE	0.211	2_CELL_CYCLE_GO_0007049	0.211	2_GABA_RECEPTOR_ACTIVITY	0.211	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.158	2_MICROTUBULE_CYTOSKELETON	0.158	2_CELL_CELL_SIGNALING	0.158	2_REGULATION_OF_CELL_CYCLE	0.158	
CD1D	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	
CD3E	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	
CD3G	9	1_KEGG_CELL_CYCLE	0.556	1_KEGG_ECM_RECEPTOR_INTERACTION	0.556	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.556	2_GABA_RECEPTOR_ACTIVITY	0.556	0_HALLMARK_G2M_CHECKPOINT	0.444	0_HALLMARK_E2F_TARGETS	0.444	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.444	1_KEGG_FOCAL_ADHESION	0.444	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.444	1_KEGG_ALLOGRAFT_REJECTION	0.444	
CD79B	1	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	
CD97	1	
CDC2	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_BLADDER_CANCER	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	
CDC23	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
CDC27	5	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	1_KEGG_CELL_CYCLE	0.800	2_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.600	1_KEGG_DNA_REPLICATION	0.400	1_KEGG_P53_SIGNALING_PATHWAY	0.400	2_MICROTUBULE_CYTOSKELETON	0.400	2_SPINDLE	0.400	2_CYTOSKELETON	0.400	
CDH15	2	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	2_AXON	0.500	
CDH17	1	
CDH18	7	
CDH19	2	
CDH20	1	
CDH22	1	
CDH23	10	2_MICROVILLUS	0.300	2_PHOTORECEPTOR_CELL_MAINTENANCE	0.300	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.200	0_HALLMARK_UV_RESPONSE_DN	0.200	1_KEGG_FOCAL_ADHESION	0.200	1_KEGG_ECM_RECEPTOR_INTERACTION	0.200	2_GABA_RECEPTOR_ACTIVITY	0.200	0_HALLMARK_G2M_CHECKPOINT	0.100	0_HALLMARK_E2F_TARGETS	0.100	0_HALLMARK_ANGIOGENESIS	0.100	
CDH5	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOME	1.000	
CDH8	2	
CDH9	7	
CDK4	37	0_HALLMARK_E2F_TARGETS	0.919	1_KEGG_CELL_CYCLE	0.919	0_HALLMARK_G2M_CHECKPOINT	0.784	2_CELL_CYCLE_GO_0007049	0.730	1_KEGG_P53_SIGNALING_PATHWAY	0.703	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.676	2_NON_MEMBRANE_BOUND_ORGANELLE	0.595	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.595	1_KEGG_ECM_RECEPTOR_INTERACTION	0.541	2_REGULATION_OF_CELL_CYCLE	0.541	
CDK5RAP2	1	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
CDK6	6	1_KEGG_CELL_CYCLE	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	0_HALLMARK_G2M_CHECKPOINT	0.833	0_HALLMARK_E2F_TARGETS	0.833	1_KEGG_PATHWAYS_IN_CANCER	0.833	1_KEGG_MELANOMA	0.833	2_CELL_CYCLE_GO_0007049	0.833	1_KEGG_P53_SIGNALING_PATHWAY	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_FOCAL_ADHESION	0.500	
CDKN2A	147	1_KEGG_CELL_CYCLE	0.816	0_HALLMARK_E2F_TARGETS	0.660	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.605	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.599	2_CELL_CYCLE_GO_0007049	0.599	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.571	2_REGULATION_OF_PHOSPHORYLATION	0.551	0_HALLMARK_G2M_CHECKPOINT	0.537	1_KEGG_P53_SIGNALING_PATHWAY	0.517	1_KEGG_ECM_RECEPTOR_INTERACTION	0.490	
CDKN2B	125	1_KEGG_CELL_CYCLE	0.856	0_HALLMARK_E2F_TARGETS	0.696	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.648	2_CELL_CYCLE_GO_0007049	0.648	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.616	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.608	2_REGULATION_OF_PHOSPHORYLATION	0.592	0_HALLMARK_G2M_CHECKPOINT	0.576	1_KEGG_P53_SIGNALING_PATHWAY	0.552	1_KEGG_ECM_RECEPTOR_INTERACTION	0.504	
CEBPB	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
CELSR1	5	2_MICROVILLUS	0.200	2_PHOTORECEPTOR_CELL_MAINTENANCE	0.200	
CELSR2	1	
CELSR3	4	
CEP135	8	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	2_CHROMOSOME	0.500	2_CELL_CYCLE_GO_0007049	0.500	0_HALLMARK_MYC_TARGETS_V1	0.375	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.375	1_KEGG_DNA_REPLICATION	0.375	1_KEGG_FOCAL_ADHESION	0.375	
CEP250	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	2_CELL_CYCLE_GO_0007049	0.667	0_HALLMARK_MITOTIC_SPINDLE	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_FOCAL_ADHESION	0.333	
CEP63	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	
CEP70	2	
CHEK1	4	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.750	2_EXTRACELLULAR_MATRIX_PART	0.750	2_EXTRACELLULAR_MATRIX	0.750	2_COLLAGEN	0.750	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.750	2_CELL_CYCLE_GO_0007049	0.750	
CHEK2	4	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.750	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.750	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.750	1_KEGG_LEISHMANIA_INFECTION	0.750	1_KEGG_ASTHMA	0.750	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.750	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.750	1_KEGG_ALLOGRAFT_REJECTION	0.750	
CHL1	5	0_HALLMARK_E2F_TARGETS	0.400	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.400	1_KEGG_CELL_CYCLE	0.400	1_KEGG_P53_SIGNALING_PATHWAY	0.400	1_KEGG_ECM_RECEPTOR_INTERACTION	0.400	1_KEGG_PATHWAYS_IN_CANCER	0.400	1_KEGG_GLIOMA	0.400	2_GABA_RECEPTOR_ACTIVITY	0.400	0_HALLMARK_G2M_CHECKPOINT	0.200	0_HALLMARK_P53_PATHWAY	0.200	
CHP2	2	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	
CIITA	1	
CLSPN	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
CNKSR2	2	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	1_KEGG_VIRAL_MYOCARDITIS	0.500	2_CELL_CELL_SIGNALING	0.500	
CNOT2	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.750	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.750	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.750	1_KEGG_LEISHMANIA_INFECTION	0.750	1_KEGG_BLADDER_CANCER	0.750	1_KEGG_ASTHMA	0.750	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.750	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	0.750	1_KEGG_ALLOGRAFT_REJECTION	0.750	
CNTN1	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_ALLOGRAFT_REJECTION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.500	1_KEGG_MISMATCH_REPAIR	0.500	
CNTN2	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	0_HALLMARK_ANGIOGENESIS	0.833	1_KEGG_CELL_CYCLE	0.833	2_REGULATION_OF_PHOSPHORYLATION	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	
CNTNAP1	2	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_ASTHMA	0.500	
COL11A2	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_CYCLE	0.750	1_KEGG_FOCAL_ADHESION	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	1_KEGG_ASTHMA	0.500	
COL14A1	5	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_COLLAGEN	1.000	0_HALLMARK_ANGIOGENESIS	0.800	2_EXTRACELLULAR_MATRIX_PART	0.800	0_HALLMARK_G2M_CHECKPOINT	0.600	0_HALLMARK_E2F_TARGETS	0.600	0_HALLMARK_UV_RESPONSE_DN	0.600	1_KEGG_CELL_CYCLE	0.600	
COL1A1	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_UV_RESPONSE_DN	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	1_KEGG_MELANOMA	0.750	
COL1A2	14	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.857	1_KEGG_CELL_CYCLE	0.786	1_KEGG_ECM_RECEPTOR_INTERACTION	0.786	0_HALLMARK_E2F_TARGETS	0.714	1_KEGG_FOCAL_ADHESION	0.714	0_HALLMARK_G2M_CHECKPOINT	0.643	2_EXTRACELLULAR_MATRIX_PART	0.571	2_COLLAGEN	0.571	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_MELANOMA	0.500	
COL2A1	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	0_HALLMARK_ANGIOGENESIS	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_EXTRACELLULAR_REGION	0.667	2_EXTRACELLULAR_REGION_PART	0.667	2_EXTRACELLULAR_MATRIX	0.667	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.333	0_HALLMARK_HYPOXIA	0.333	
COL4A1	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_UV_RESPONSE_DN	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_MELANOMA	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	
COL4A3	1	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	
COL4A5	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	
COL5A2	2	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	
COL6A1	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	
COL6A2	9	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.889	1_KEGG_FOCAL_ADHESION	0.889	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_G2M_CHECKPOINT	0.556	0_HALLMARK_E2F_TARGETS	0.556	1_KEGG_CELL_CYCLE	0.556	1_KEGG_MELANOMA	0.556	1_KEGG_P53_SIGNALING_PATHWAY	0.444	2_EXTRACELLULAR_MATRIX_PART	0.444	
COL6A3	11	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.909	1_KEGG_ECM_RECEPTOR_INTERACTION	0.909	2_GABA_RECEPTOR_ACTIVITY	0.818	1_KEGG_FOCAL_ADHESION	0.727	2_COLLAGEN	0.727	0_HALLMARK_E2F_TARGETS	0.545	1_KEGG_CELL_CYCLE	0.545	2_EXTRACELLULAR_MATRIX_PART	0.545	2_CELL_CELL_SIGNALING	0.545	0_HALLMARK_G2M_CHECKPOINT	0.455	
CREBBP	5	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_CELL_CYCLE	0.600	2_REGULATION_OF_PHOSPHORYLATION	0.600	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.600	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.600	0_HALLMARK_G2M_CHECKPOINT	0.400	0_HALLMARK_E2F_TARGETS	0.400	0_HALLMARK_ANGIOGENESIS	0.400	1_KEGG_P53_SIGNALING_PATHWAY	0.400	1_KEGG_FOCAL_ADHESION	0.400	
CRKL	2	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	
CSNK1G1	1	
CSNK2B	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	2_INTERPHASE	0.667	2_CELL_CYCLE_PROCESS	0.667	2_MITOTIC_CELL_CYCLE	0.667	2_CELL_CYCLE_PHASE	0.667	
CTBP1	1	
CTDSP2	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.833	1_KEGG_ECM_RECEPTOR_INTERACTION	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_BLADDER_CANCER	0.667	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_DNA_REPLICATION	0.500	
CTNNA2	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.333	
CTNNB1	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	
CUBN	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_COAGULATION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	
CUGBP2	1	
DACH1	1	
DBF4	3	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_MELANOMA	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_CELL_PROLIFERATION_GO_0008283	0.667	2_CELL_CYCLE_GO_0007049	0.667	
DBNL	4	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_CELL_CYCLE_GO_0007049	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	0_HALLMARK_APOPTOSIS	0.250	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	
DCHS1	2	
DCHS2	5	
DCTN2	20	0_HALLMARK_E2F_TARGETS	0.650	1_KEGG_CELL_CYCLE	0.650	0_HALLMARK_G2M_CHECKPOINT	0.600	2_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_CELL_CYCLE_GO_0007049	0.600	1_KEGG_P53_SIGNALING_PATHWAY	0.550	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	2_REGULATION_OF_CELL_CYCLE	0.500	2_MICROTUBULE_CYTOSKELETON	0.450	
DDB1	1	0_HALLMARK_DNA_REPAIR	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	1.000	1_KEGG_MISMATCH_REPAIR	1.000	1_KEGG_CELL_CYCLE	1.000	2_NUCLEAR_REPLICATION_FORK	1.000	2_NUCLEAR_CHROMOSOME	1.000	
DDIT3	6	1_KEGG_P53_SIGNALING_PATHWAY	0.667	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_BLADDER_CANCER	0.500	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	
DFFB	3	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	
DLG1	1	2_PHOSPHOTRANSFERASE_ACTIVITY_PHOSPHATE_GROUP_AS_ACCEPTOR	1.000	2_NUCLEOTIDE_KINASE_ACTIVITY	1.000	2_NUCLEOBASENUCLEOSIDENUCLEOTIDE_KINASE_ACTIVITY	1.000	
DLG4	2	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	
DMD	9	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	0.889	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.778	2_EXTRACELLULAR_MATRIX_PART	0.778	2_EXTRACELLULAR_MATRIX	0.778	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	0_HALLMARK_ANGIOGENESIS	0.556	
DNAH9	9	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.556	2_EXTRACELLULAR_MATRIX_PART	0.556	2_EXTRACELLULAR_MATRIX	0.556	2_COLLAGEN	0.556	0_HALLMARK_E2F_TARGETS	0.444	1_KEGG_CELL_CYCLE	0.444	1_KEGG_PATHWAYS_IN_CANCER	0.444	
DNMBP	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	0.833	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_MELANOMA	0.500	
DNMT1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	1.000	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	
DOCK1	1	2_PHAGOCYTOSIS	1.000	
DOCK2	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	0_HALLMARK_UV_RESPONSE_DN	0.750	0_HALLMARK_ANGIOGENESIS	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	1_KEGG_MELANOMA	0.750	2_EXTRACELLULAR_MATRIX_PART	0.750	2_COLLAGEN	0.750	2_ENZYME_REGULATOR_ACTIVITY	0.750	1_KEGG_CELL_CYCLE	0.500	
DRD5	9	2_GABA_RECEPTOR_ACTIVITY	0.889	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	0_HALLMARK_G2M_CHECKPOINT	0.556	0_HALLMARK_E2F_TARGETS	0.556	1_KEGG_CELL_CYCLE	0.556	1_KEGG_FOCAL_ADHESION	0.444	2_CELL_CELL_SIGNALING	0.444	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.444	2_CELL_CYCLE_GO_0007049	0.444	
DSP	4	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CELL_CYCLE_GO_0007049	1.000	1_KEGG_DNA_REPLICATION	0.750	
DYRK1B	1	
E2F4	1	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	1.000	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_INFLAMMATORY_RESPONSE	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	0_HALLMARK_COAGULATION	1.000	
EEF1A1	3	
EGF	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_MELANOMA	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	
EGFR	129	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.822	1_KEGG_ECM_RECEPTOR_INTERACTION	0.721	1_KEGG_FOCAL_ADHESION	0.713	2_GABA_RECEPTOR_ACTIVITY	0.620	1_KEGG_CELL_CYCLE	0.566	0_HALLMARK_E2F_TARGETS	0.504	2_CELL_CELL_SIGNALING	0.450	1_KEGG_MELANOMA	0.442	0_HALLMARK_G2M_CHECKPOINT	0.411	0_HALLMARK_ANGIOGENESIS	0.380	
EGR1	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_MELANOMA	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.667	
EIF4A1	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	1.000	1_KEGG_PANCREATIC_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	1_KEGG_NON_SMALL_CELL_LUNG_CANCER	1.000	2_AXON	1.000	
ELAVL1	1	
ELAVL2	29	2_MRNA_BINDING	1.000	
EP300	3	2_GABA_RECEPTOR_ACTIVITY	1.000	1_KEGG_CELL_CYCLE	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	2_CELL_CELL_SIGNALING	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_E2F_TARGETS	0.333	
EPC1	6	0_HALLMARK_G2M_CHECKPOINT	0.833	0_HALLMARK_E2F_TARGETS	0.833	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.833	1_KEGG_CELL_CYCLE	0.833	1_KEGG_P53_SIGNALING_PATHWAY	0.833	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_BLADDER_CANCER	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	
EPHA1	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.500	1_KEGG_MISMATCH_REPAIR	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_AXON_GUIDANCE	0.500	
EPS8	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	
ERBB2	7	0_HALLMARK_UV_RESPONSE_DN	0.857	1_KEGG_FOCAL_ADHESION	0.857	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.714	1_KEGG_ECM_RECEPTOR_INTERACTION	0.714	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.714	2_EXTRACELLULAR_MATRIX	0.714	2_EXTRACELLULAR_MATRIX_PART	0.571	2_COLLAGEN	0.571	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.571	0_HALLMARK_ANGIOGENESIS	0.429	
ERBB4	1	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_ASTHMA	1.000	
ERCC6L	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_SMALL_CELL_LUNG_CANCER	0.500	
ERG	4	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_DNA_REPLICATION	0.750	2_NON_MEMBRANE_BOUND_ORGANELLE	0.750	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.750	2_DNA_METABOLIC_PROCESS	0.750	2_REGULATION_OF_PHOSPHORYLATION	0.750	
ESR1	1	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	1.000	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_INFLAMMATORY_RESPONSE	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	0_HALLMARK_COAGULATION	1.000	
ETS2	1	0_HALLMARK_MITOTIC_SPINDLE	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	
EZH2	4	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	1_KEGG_PATHWAYS_IN_CANCER	0.750	1_KEGG_MELANOMA	0.750	2_CELL_CYCLE_GO_0007049	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_ANGIOGENESIS	0.500	
EZR	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	
F10	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_REGION	1.000	2_EXTRACELLULAR_REGION_PART	1.000	
F2	2	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	
F8	5	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	2_CELL_CELL_SIGNALING	0.400	2_GABA_RECEPTOR_ACTIVITY	0.400	0_HALLMARK_COMPLEMENT	0.200	0_HALLMARK_E2F_TARGETS	0.200	0_HALLMARK_P53_PATHWAY	0.200	0_HALLMARK_UV_RESPONSE_DN	0.200	0_HALLMARK_COAGULATION	0.200	1_KEGG_DNA_REPLICATION	0.200	
F9	3	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_APICAL_JUNCTION	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_ANGIOGENESIS	0.333	0_HALLMARK_COAGULATION	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_FOCAL_ADHESION	0.333	
FAS	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.833	0_HALLMARK_E2F_TARGETS	0.833	1_KEGG_CELL_CYCLE	0.833	1_KEGG_P53_SIGNALING_PATHWAY	0.833	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_BLADDER_CANCER	0.667	2_CELL_CYCLE_GO_0007049	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	
FAT2	9	
FBLN1	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_GLIOMA	0.667	1_KEGG_PROSTATE_CANCER	0.667	
FBLN2	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_CYCLE	0.833	1_KEGG_P53_SIGNALING_PATHWAY	0.833	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.833	2_EXTRACELLULAR_MATRIX	0.833	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.833	2_CELL_CYCLE_GO_0007049	0.833	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.833	
FBN2	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.833	1_KEGG_FOCAL_ADHESION	0.833	0_HALLMARK_ANGIOGENESIS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_EXTRACELLULAR_MATRIX	0.667	2_COLLAGEN	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	
FCER1A	1	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
FGF13	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	
FGF18	2	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_INFLAMMATORY_RESPONSE	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_COAGULATION	0.500	0_HALLMARK_ALLOGRAFT_REJECTION	0.500	0_HALLMARK_KRAS_SIGNALING_UP	0.500	
FGFR1	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	1_KEGG_FOCAL_ADHESION	0.750	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	
FGFR2	9	0_HALLMARK_E2F_TARGETS	0.778	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.778	1_KEGG_CELL_CYCLE	0.778	0_HALLMARK_G2M_CHECKPOINT	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.556	1_KEGG_MELANOMA	0.556	2_NON_MEMBRANE_BOUND_ORGANELLE	0.556	
FGFR3	5	0_HALLMARK_E2F_TARGETS	0.600	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.600	0_HALLMARK_UV_RESPONSE_DN	0.600	1_KEGG_CELL_CYCLE	0.600	1_KEGG_FOCAL_ADHESION	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.600	1_KEGG_PATHWAYS_IN_CANCER	0.600	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.600	2_EXTRACELLULAR_MATRIX_PART	0.600	
FGFR4	4	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	2_CELL_CYCLE_PROCESS	0.750	2_MITOTIC_CELL_CYCLE	0.750	2_CELL_CYCLE_PHASE	0.750	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.750	
FLI1	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_ENDOMETRIAL_CANCER	0.667	1_KEGG_GLIOMA	0.667	
FLNA	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.833	1_KEGG_FOCAL_ADHESION	0.833	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_COLLAGEN	0.667	0_HALLMARK_UV_RESPONSE_DN	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_G2M_CHECKPOINT	0.333	
FLNB	2	1_KEGG_FOCAL_ADHESION	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	
FLNC	8	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.875	1_KEGG_FOCAL_ADHESION	0.875	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_MELANOMA	0.500	2_CELL_CYCLE_GO_0007049	0.500	0_HALLMARK_ANGIOGENESIS	0.375	
FLT1	6	0_HALLMARK_G2M_CHECKPOINT	0.833	0_HALLMARK_E2F_TARGETS	0.833	1_KEGG_CELL_CYCLE	0.833	2_CELL_CYCLE_GO_0007049	0.833	2_GABA_RECEPTOR_ACTIVITY	0.833	1_KEGG_P53_SIGNALING_PATHWAY	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_GLIOMA	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	
FN1	6	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_G2M_CHECKPOINT	0.833	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.833	1_KEGG_ECM_RECEPTOR_INTERACTION	0.833	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_MELANOMA	0.667	2_CELL_CYCLE_GO_0007049	0.667	
FOS	1	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_INFLAMMATORY_RESPONSE	1.000	0_HALLMARK_ANGIOGENESIS	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	
FOXG1	1	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
FOXO3	1	2_REGULATION_OF_CELL_DIFFERENTIATION	1.000	
FRS2	8	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.625	1_KEGG_ECM_RECEPTOR_INTERACTION	0.625	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	2_CELL_CELL_SIGNALING	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_G2M_CHECKPOINT	0.375	0_HALLMARK_E2F_TARGETS	0.375	1_KEGG_DNA_REPLICATION	0.375	
FRYL	1	1_KEGG_ONE_CARBON_POOL_BY_FOLATE	1.000	
FZD10	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_WNT_SIGNALING_PATHWAY	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	
FZD4	1	
GABBR2	1	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	1.000	2_PLASMA_MEMBRANE	1.000	2_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
GABRA1	5	0_HALLMARK_E2F_TARGETS	0.600	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.600	1_KEGG_CELL_CYCLE	0.600	1_KEGG_P53_SIGNALING_PATHWAY	0.600	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.600	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.600	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.600	1_KEGG_ASTHMA	0.600	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.600	1_KEGG_ALLOGRAFT_REJECTION	0.600	
GABRA5	3	2_GABA_RECEPTOR_ACTIVITY	1.000	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	
GABRA6	8	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.625	1_KEGG_CELL_CYCLE	0.625	2_GABA_RECEPTOR_ACTIVITY	0.625	0_HALLMARK_G2M_CHECKPOINT	0.375	0_HALLMARK_E2F_TARGETS	0.375	1_KEGG_FOCAL_ADHESION	0.375	1_KEGG_ECM_RECEPTOR_INTERACTION	0.375	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.375	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.375	1_KEGG_LEISHMANIA_INFECTION	0.375	
GABRB2	5	2_CELL_CELL_SIGNALING	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.600	2_SYNAPTIC_TRANSMISSION	0.600	2_TRANSMISSION_OF_NERVE_IMPULSE	0.600	0_HALLMARK_COMPLEMENT	0.400	0_HALLMARK_ALLOGRAFT_REJECTION	0.400	0_HALLMARK_KRAS_SIGNALING_UP	0.400	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.400	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.400	
GABRB3	7	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.571	1_KEGG_ECM_RECEPTOR_INTERACTION	0.571	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.429	0_HALLMARK_UV_RESPONSE_DN	0.429	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	0.429	1_KEGG_FOCAL_ADHESION	0.429	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.429	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.429	1_KEGG_ASTHMA	0.429	
GABRG2	3	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	0_HALLMARK_COAGULATION	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_EXTRACELLULAR_REGION	0.667	2_EXTRACELLULAR_REGION_PART	0.667	0_HALLMARK_HYPOXIA	0.333	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	
GABRQ	1	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	
GLI1	13	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.692	0_HALLMARK_E2F_TARGETS	0.538	1_KEGG_CELL_CYCLE	0.538	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.538	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.538	1_KEGG_LEISHMANIA_INFECTION	0.538	1_KEGG_ASTHMA	0.538	1_KEGG_ALLOGRAFT_REJECTION	0.538	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.538	0_HALLMARK_APOPTOSIS	0.462	
GLI2	1	
GLI3	6	0_HALLMARK_E2F_TARGETS	0.833	1_KEGG_CELL_CYCLE	0.833	2_GABA_RECEPTOR_ACTIVITY	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_CELL_CYCLE_GO_0007049	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	
GNA15	1	2_G_PROTEIN_SIGNALING_COUPLED_TO_IP3_SECOND_MESSENGERPHOSPHOLIPASE_C_ACTIVATING	1.000	2_PHOSPHOLIPASE_C_ACTIVATION	1.000	2_POSITIVE_REGULATION_OF_HYDROLASE_ACTIVITY	1.000	2_PHOSPHOINOSITIDE_MEDIATED_SIGNALING	1.000	
GNAO1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_CELL_CYCLE_PROCESS	1.000	2_SYNAPTIC_TRANSMISSION	1.000	
GNAT3	8	1_KEGG_ECM_RECEPTOR_INTERACTION	0.375	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_E2F_TARGETS	0.250	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_CELL_CYCLE	0.250	1_KEGG_FOCAL_ADHESION	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.250	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.250	
GNG12	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_COAGULATION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	
GRASP	1	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	1.000	2_INTRINSIC_TO_PLASMA_MEMBRANE	1.000	2_INTRINSIC_TO_MEMBRANE	1.000	2_INTEGRAL_TO_MEMBRANE	1.000	2_INTEGRAL_TO_PLASMA_MEMBRANE	1.000	2_PLASMA_MEMBRANE_PART	1.000	2_G_PROTEIN_COUPLED_RECEPTOR_PROTEIN_SIGNALING_PATHWAY	1.000	2_METABOTROPIC_GLUTAMATEGABA_B_LIKE_RECEPTOR_ACTIVITY	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	2_RECEPTOR_ACTIVITY	1.000	
GRB10	7	0_HALLMARK_G2M_CHECKPOINT	0.714	0_HALLMARK_E2F_TARGETS	0.714	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.714	1_KEGG_CELL_CYCLE	0.714	1_KEGG_FOCAL_ADHESION	0.571	1_KEGG_ECM_RECEPTOR_INTERACTION	0.571	1_KEGG_MELANOMA	0.571	2_CELL_CYCLE_GO_0007049	0.571	0_HALLMARK_ANGIOGENESIS	0.429	1_KEGG_DNA_REPLICATION	0.429	
GRB2	1	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
GRID2	1	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_NEUROLOGICAL_SYSTEM_PROCESS	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_SYSTEM_PROCESS	1.000	2_GLUTAMATE_RECEPTOR_ACTIVITY	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
GRIN2A	8	2_CELL_CELL_SIGNALING	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	2_SYNAPTIC_TRANSMISSION	0.375	2_TRANSMISSION_OF_NERVE_IMPULSE	0.375	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.250	1_KEGG_FOCAL_ADHESION	0.250	1_KEGG_ECM_RECEPTOR_INTERACTION	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_PATHWAYS_IN_CANCER	0.250	2_AXON	0.250	
GRIN2C	2	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	0.500	2_CELL_CELL_SIGNALING	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	2_GLUTAMATE_RECEPTOR_ACTIVITY	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	2_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY	0.500	
GRK5	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_PANCREATIC_CANCER	0.500	
HCLS1	3	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX	0.667	2_CELL_CELL_SIGNALING	0.667	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	
HDAC2	4	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	2_CELL_CYCLE_GO_0007049	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	1_KEGG_MELANOMA	0.750	2_NON_MEMBRANE_BOUND_ORGANELLE	0.750	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.750	2_CHROMOSOMAL_PART	0.750	
HGF	6	1_KEGG_FOCAL_ADHESION	0.667	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	2_CELL_CELL_SIGNALING	0.500	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	1_KEGG_SMALL_CELL_LUNG_CANCER	0.333	
HLA-A	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	0_HALLMARK_KRAS_SIGNALING_UP	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	
HLA-DOA	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	
HLA-DQB1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_MELANOMA	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	
HLA-DRA	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_COAGULATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	
HLA-DRB1	62	1_KEGG_ASTHMA	0.694	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.661	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.661	1_KEGG_ALLOGRAFT_REJECTION	0.661	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.661	1_KEGG_VIRAL_MYOCARDITIS	0.661	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.645	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.613	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.613	1_KEGG_LEISHMANIA_INFECTION	0.613	
HLF	1	
HMHA1	2	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	
HNRNPA2B1	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	0_HALLMARK_MYC_TARGETS_V1	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	2_ORGANELLE_PART	0.667	
HNRNPH3	1	2_RNA_PROCESSING	1.000	
HOXA2	1	
HOXA9	3	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	2_MICROTUBULE_CYTOSKELETON	0.667	2_CELL_CELL_SIGNALING	0.667	2_SYNAPTIC_TRANSMISSION	0.667	2_CELL_CYCLE_GO_0007049	0.667	
HSPA8	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_COLLAGEN	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	2_CELL_CELL_SIGNALING	0.500	
IFI16	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	
IFNG	11	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.818	0_HALLMARK_E2F_TARGETS	0.727	1_KEGG_CELL_CYCLE	0.727	0_HALLMARK_G2M_CHECKPOINT	0.636	1_KEGG_FOCAL_ADHESION	0.636	1_KEGG_ECM_RECEPTOR_INTERACTION	0.636	1_KEGG_BLADDER_CANCER	0.636	1_KEGG_P53_SIGNALING_PATHWAY	0.545	2_CELL_CYCLE_GO_0007049	0.545	2_GABA_RECEPTOR_ACTIVITY	0.545	
IFNGR1	1	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	
IGF1R	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_MELANOMA	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX	1.000	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.500	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	
IGF2R	2	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	0_HALLMARK_COAGULATION	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	0_HALLMARK_KRAS_SIGNALING_UP	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	
IGFBP3	6	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	2_NON_MEMBRANE_BOUND_ORGANELLE	0.333	2_NUCLEUS	0.333	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.333	
IGFBP7	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_REGION_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	
IKBKE	1	
IKZF1	10	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	1_KEGG_CELL_CYCLE	0.800	2_CELL_CYCLE_GO_0007049	0.800	2_REGULATION_OF_CELL_CYCLE	0.600	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	1_KEGG_DNA_REPLICATION	0.400	1_KEGG_FOCAL_ADHESION	0.400	
IKZF3	2	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.500	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_INFLAMMATORY_RESPONSE	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_COAGULATION	0.500	
IL12B	1	
IL12RB2	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	0_HALLMARK_MITOTIC_SPINDLE	0.333	
IL32	1	
IL7	1	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	1.000	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_EXTRACELLULAR_REGION	1.000	2_COLLAGEN	1.000	2_RESPONSE_TO_EXTERNAL_STIMULUS	1.000	2_RESPONSE_TO_WOUNDING	1.000	
ING3	3	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_DNA_REPLICATION	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	1_KEGG_DNA_REPLICATION	0.667	
INSR	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	
ITGA1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.500	
ITGA10	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	0_HALLMARK_ANGIOGENESIS	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_REGION_PART	0.667	2_EXTRACELLULAR_MATRIX	0.667	2_COLLAGEN	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.333	
ITGA4	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_COLLAGEN	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.667	0_HALLMARK_COMPLEMENT	0.667	0_HALLMARK_UV_RESPONSE_DN	0.667	0_HALLMARK_ANGIOGENESIS	0.667	0_HALLMARK_COAGULATION	0.667	
ITGA7	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.500	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_MYOGENESIS	0.500	
ITGA8	5	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.600	0_HALLMARK_E2F_TARGETS	0.600	0_HALLMARK_ANGIOGENESIS	0.600	1_KEGG_CELL_CYCLE	0.600	1_KEGG_P53_SIGNALING_PATHWAY	0.600	1_KEGG_PATHWAYS_IN_CANCER	0.600	1_KEGG_BLADDER_CANCER	0.600	
ITGAM	5	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	1_KEGG_CELL_CYCLE	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	2_COLLAGEN	0.800	2_GABA_RECEPTOR_ACTIVITY	0.800	0_HALLMARK_UV_RESPONSE_DN	0.600	1_KEGG_P53_SIGNALING_PATHWAY	0.600	
ITGAX	5	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.600	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.600	2_GABA_RECEPTOR_ACTIVITY	0.600	0_HALLMARK_G2M_CHECKPOINT	0.400	0_HALLMARK_E2F_TARGETS	0.400	0_HALLMARK_UV_RESPONSE_DN	0.400	1_KEGG_CELL_CYCLE	0.400	
ITGB1	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_BLADDER_CANCER	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	
ITGB2	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_FOCAL_ADHESION	0.667	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_MELANOMA	0.333	2_COLLAGEN	0.333	
ITGB3	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_UV_RESPONSE_DN	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	1_KEGG_MELANOMA	0.750	2_NON_MEMBRANE_BOUND_ORGANELLE	0.750	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.750	
ITGB4	4	2_GABA_RECEPTOR_ACTIVITY	1.000	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	2_CELL_CELL_SIGNALING	0.750	2_SYNAPTIC_TRANSMISSION	0.750	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.750	2_TRANSMISSION_OF_NERVE_IMPULSE	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_COMPLEMENT	0.250	
ITGB7	3	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.667	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.667	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.667	
ITGB8	5	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	1_KEGG_CELL_CYCLE	0.800	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	2_CELL_CYCLE_GO_0007049	0.800	0_HALLMARK_MYC_TARGETS_V1	0.600	1_KEGG_DNA_REPLICATION	0.600	1_KEGG_P53_SIGNALING_PATHWAY	0.600	2_NUCLEUS	0.600	
ITPR1	4	2_CELL_CELL_SIGNALING	0.500	2_SYNAPTIC_TRANSMISSION	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	2_RECEPTOR_ACTIVITY	0.500	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.250	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	0.250	1_KEGG_OOCYTE_MEIOSIS	0.250	2_NEUROLOGICAL_SYSTEM_PROCESS	0.250	
ITSN1	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CELL_CYCLE_PROCESS	1.000	2_CELL_CYCLE_PHASE	1.000	
JAK1	2	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	
KALRN	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	
KCNA4	2	
KCNB1	2	
KCNB2	4	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.250	0_HALLMARK_ANGIOGENESIS	0.250	1_KEGG_CELL_CYCLE	0.250	1_KEGG_P53_SIGNALING_PATHWAY	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.250	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.250	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.250	1_KEGG_LEISHMANIA_INFECTION	0.250	
KCNG1	3	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.333	
KCNH1	2	
KCNJ4	1	
KCNS3	2	2_AUXILIARY_TRANSPORT_PROTEIN_ACTIVITY	0.500	2_POTASSIUM_CHANNEL_REGULATOR_ACTIVITY	0.500	2_CHANNEL_REGULATOR_ACTIVITY	0.500	
KCNV1	2	
KCNV2	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	
KDR	18	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.778	1_KEGG_FOCAL_ADHESION	0.778	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	0_HALLMARK_UV_RESPONSE_DN	0.611	1_KEGG_CELL_CYCLE	0.556	1_KEGG_PATHWAYS_IN_CANCER	0.556	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	2_COLLAGEN	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
KIF15	1	
KIF5A	12	2_MICROTUBULE_CYTOSKELETON	0.583	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	0_HALLMARK_G2M_CHECKPOINT	0.417	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.417	1_KEGG_P53_SIGNALING_PATHWAY	0.417	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.417	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.417	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.417	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.417	
KIFC3	1	
KIR3DL2	2	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_SYSTEMIC_LUPUS_ERYTHEMATOSUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	1_KEGG_VIRAL_MYOCARDITIS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	
KIT	24	1_KEGG_FOCAL_ADHESION	0.708	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.625	1_KEGG_CELL_CYCLE	0.583	0_HALLMARK_G2M_CHECKPOINT	0.542	0_HALLMARK_E2F_TARGETS	0.542	0_HALLMARK_UV_RESPONSE_DN	0.542	1_KEGG_P53_SIGNALING_PATHWAY	0.542	1_KEGG_MELANOMA	0.542	
KLC2	1	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_KINESIN_COMPLEX	1.000	
KLHL9	34	0_HALLMARK_E2F_TARGETS	0.441	1_KEGG_CELL_CYCLE	0.441	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.412	0_HALLMARK_G2M_CHECKPOINT	0.382	1_KEGG_P53_SIGNALING_PATHWAY	0.382	1_KEGG_ECM_RECEPTOR_INTERACTION	0.353	1_KEGG_FOCAL_ADHESION	0.324	2_REGULATION_OF_PHOSPHORYLATION	0.294	2_COLLAGEN	0.265	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.265	
LAMA1	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_UV_RESPONSE_DN	0.667	0_HALLMARK_ANGIOGENESIS	0.667	1_KEGG_CELL_CYCLE	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_E2F_TARGETS	0.500	
LAMA2	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.833	1_KEGG_ECM_RECEPTOR_INTERACTION	0.833	0_HALLMARK_UV_RESPONSE_DN	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_COAGULATION	0.500	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	
LAMA3	4	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	2_GABA_RECEPTOR_ACTIVITY	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_GLIOMA	0.500	
LAMA4	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	
LAMA5	5	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.600	1_KEGG_ASTHMA	0.600	2_EXTRACELLULAR_MATRIX_PART	0.600	2_GABA_RECEPTOR_ACTIVITY	0.600	0_HALLMARK_COMPLEMENT	0.400	0_HALLMARK_UV_RESPONSE_DN	0.400	0_HALLMARK_ANGIOGENESIS	0.400	
LAMB1	5	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	1_KEGG_MELANOMA	0.800	0_HALLMARK_G2M_CHECKPOINT	0.600	0_HALLMARK_E2F_TARGETS	0.600	1_KEGG_CELL_CYCLE	0.600	1_KEGG_SMALL_CELL_LUNG_CANCER	0.600	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.600	
LAMB3	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_CELL_CYCLE	0.750	2_CELL_CYCLE_GO_0007049	0.750	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_MELANOMA	0.500	
LAMB4	6	1_KEGG_CELL_CYCLE	0.833	1_KEGG_FOCAL_ADHESION	0.833	1_KEGG_ECM_RECEPTOR_INTERACTION	0.833	1_KEGG_PATHWAYS_IN_CANCER	0.833	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_MELANOMA	0.500	
LAMC1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_BLADDER_CANCER	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	
LAMC3	5	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	1_KEGG_CELL_CYCLE	0.800	1_KEGG_P53_SIGNALING_PATHWAY	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	1_KEGG_SMALL_CELL_LUNG_CANCER	0.800	2_CELL_CYCLE_GO_0007049	0.800	1_KEGG_FOCAL_ADHESION	0.600	
LILRB3	3	1_KEGG_ASTHMA	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.667	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.667	1_KEGG_LEISHMANIA_INFECTION	0.667	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	0.667	1_KEGG_ALLOGRAFT_REJECTION	0.667	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.667	1_KEGG_VIRAL_MYOCARDITIS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	
LRP1	11	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.909	0_HALLMARK_UV_RESPONSE_DN	0.727	1_KEGG_CELL_CYCLE	0.636	1_KEGG_ECM_RECEPTOR_INTERACTION	0.636	2_EXTRACELLULAR_MATRIX_PART	0.636	0_HALLMARK_E2F_TARGETS	0.545	1_KEGG_P53_SIGNALING_PATHWAY	0.545	1_KEGG_FOCAL_ADHESION	0.545	2_GABA_RECEPTOR_ACTIVITY	0.545	0_HALLMARK_G2M_CHECKPOINT	0.455	
LRP2	8	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.875	1_KEGG_FOCAL_ADHESION	0.875	1_KEGG_ECM_RECEPTOR_INTERACTION	0.875	0_HALLMARK_G2M_CHECKPOINT	0.625	0_HALLMARK_E2F_TARGETS	0.625	0_HALLMARK_ANGIOGENESIS	0.625	1_KEGG_DNA_REPLICATION	0.625	1_KEGG_CELL_CYCLE	0.625	1_KEGG_P53_SIGNALING_PATHWAY	0.625	2_GABA_RECEPTOR_ACTIVITY	0.625	
LRP8	1	2_GLUTAMATE_RECEPTOR_ACTIVITY	1.000	2_IONOTROPIC_GLUTAMATE_RECEPTOR_ACTIVITY	1.000	
LRRC7	5	0_HALLMARK_G2M_CHECKPOINT	0.200	0_HALLMARK_E2F_TARGETS	0.200	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.200	0_HALLMARK_COAGULATION	0.200	1_KEGG_DNA_REPLICATION	0.200	1_KEGG_CELL_CYCLE	0.200	1_KEGG_P53_SIGNALING_PATHWAY	0.200	1_KEGG_FOCAL_ADHESION	0.200	1_KEGG_ECM_RECEPTOR_INTERACTION	0.200	1_KEGG_SMALL_CELL_LUNG_CANCER	0.200	
LUM	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_REGION_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	0_HALLMARK_UV_RESPONSE_DN	0.667	0_HALLMARK_ANGIOGENESIS	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_EXTRACELLULAR_REGION	0.667	
LYN	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_BLADDER_CANCER	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	
MACF1	3	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_GLIOMA	0.333	
MAG	1	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	
MAP2K3	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_CELL_CYCLE_PROCESS	1.000	2_SYNAPTIC_TRANSMISSION	1.000	
MAP3K4	3	1_KEGG_CELL_CYCLE	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	
MAP4K1	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	0_HALLMARK_ALLOGRAFT_REJECTION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.667	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.667	
MAPK1	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	
MAPK8	6	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.833	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.833	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	2_MICROTUBULE_CYTOSKELETON	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	
MAPKAPK3	1	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	1.000	2_AXON	1.000	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	2_NEURON_PROJECTION	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
MASTL	4	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	2_CELL_CYCLE_GO_0007049	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	
MCM3	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	2_CELL_CYCLE_GO_0007049	1.000	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	
MCM4	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	
MCM5	3	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.667	2_DNA_METABOLIC_PROCESS	0.667	2_INTERPHASE	0.667	
MCM6	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_COLLAGEN	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_UV_RESPONSE_DN	0.333	
MCM7	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_DNA_REPLICATION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_MELANOMA	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_REPLICATION_FORK	0.667	
MDM2	16	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.875	0_HALLMARK_E2F_TARGETS	0.813	1_KEGG_CELL_CYCLE	0.813	1_KEGG_ECM_RECEPTOR_INTERACTION	0.813	0_HALLMARK_G2M_CHECKPOINT	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.688	1_KEGG_BLADDER_CANCER	0.688	2_CELL_CYCLE_GO_0007049	0.625	2_GABA_RECEPTOR_ACTIVITY	0.625	
MDM4	5	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	2_CELL_CYCLE_GO_0007049	0.800	0_HALLMARK_APOPTOSIS	0.600	1_KEGG_DNA_REPLICATION	0.600	
MED13	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.667	0_HALLMARK_HYPOXIA	0.667	1_KEGG_MELANOMA	0.667	2_EXTRACELLULAR_REGION	0.667	2_COLLAGEN	0.667	2_RESPONSE_TO_EXTERNAL_STIMULUS	0.667	
MELK	2	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	2_AXON	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_NEURON_PROJECTION	0.500	2_INTERPHASE	0.500	
MET	10	1_KEGG_FOCAL_ADHESION	0.900	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	1_KEGG_MELANOMA	0.700	1_KEGG_PATHWAYS_IN_CANCER	0.600	2_GABA_RECEPTOR_ACTIVITY	0.600	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	
MLL	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	0_HALLMARK_UV_RESPONSE_DN	0.667	0_HALLMARK_ANGIOGENESIS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	
MLLT4	5	1_KEGG_CELL_CYCLE	0.800	0_HALLMARK_G2M_CHECKPOINT	0.600	0_HALLMARK_E2F_TARGETS	0.600	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.600	0_HALLMARK_UV_RESPONSE_DN	0.600	1_KEGG_P53_SIGNALING_PATHWAY	0.600	1_KEGG_FOCAL_ADHESION	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	2_EXTRACELLULAR_MATRIX_PART	0.600	0_HALLMARK_MYC_TARGETS_V1	0.400	
MMP7	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_REGION	1.000	2_EXTRACELLULAR_REGION_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	
MNDA	1	
MORF4L1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	2_AXON	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_NEURON_PROJECTION	1.000	2_REGULATION_OF_KINASE_ACTIVITY	1.000	2_REGULATION_OF_PROTEIN_KINASE_ACTIVITY	1.000	
MRE11A	1	
MSH6	5	0_HALLMARK_E2F_TARGETS	0.800	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_CELL_CYCLE	0.800	1_KEGG_P53_SIGNALING_PATHWAY	0.800	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	1_KEGG_MELANOMA	0.800	2_CELL_CYCLE_GO_0007049	0.800	2_GABA_RECEPTOR_ACTIVITY	0.800	0_HALLMARK_G2M_CHECKPOINT	0.600	
MVP	1	
MXD1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_INTERPHASE	1.000	2_CELL_CYCLE_PROCESS	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CYCLE_PHASE	1.000	2_CELL_CELL_SIGNALING	1.000	2_CELL_CYCLE_CHECKPOINT_GO_0000075	1.000	
MYBL1	1	
MYF5	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_ASTHMA	0.500	
MYOD1	1	
MYOG	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	
MYST4	4	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	1_KEGG_MELANOMA	0.750	2_GABA_RECEPTOR_ACTIVITY	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	
NAP1L1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	
NBN	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	1.000	
NCAPG	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_OOCYTE_MEIOSIS	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_GLIOMA	0.500	
NCAPH	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	
NCF1	6	1_KEGG_ECM_RECEPTOR_INTERACTION	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	2_CELL_CYCLE_GO_0007049	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_MELANOMA	0.500	
NCL	1	
NDN	1	
NEFH	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	1.000	2_AXON	1.000	2_NEURON_PROJECTION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
NEK2	2	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_KINESIN_COMPLEX	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_NEGATIVE_REGULATION_OF_CELL_CYCLE	0.500	2_INTERPHASE	0.500	
NF1	18	2_GABA_RECEPTOR_ACTIVITY	0.722	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_EXTRACELLULAR_MATRIX_PART	0.556	2_COLLAGEN	0.556	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_CELL_CYCLE	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX	0.500	
NFATC1	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
NFKBIA	1	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	
NGF	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_BLADDER_CANCER	0.500	2_DNA_METABOLIC_PROCESS	0.500	2_CELL_CYCLE_PROCESS	0.500	2_SYNAPTIC_TRANSMISSION	0.500	
NID1	1	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_NEUROLOGICAL_SYSTEM_PROCESS	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_SYSTEM_PROCESS	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	2_RECEPTOR_ACTIVITY	1.000	
NKX3-2	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CYCLE_CHECKPOINT_GO_0000075	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	1.000	
NLRP12	1	2_REGULATION_OF_SECRETION	1.000	2_REGULATION_OF_CYTOKINE_SECRETION	1.000	2_INTERLEUKIN_1_SECRETION	1.000	2_PROTEIN_SECRETION	1.000	2_REGULATION_OF_PROTEIN_SECRETION	1.000	2_CYTOKINE_SECRETION	1.000	
NOD1	4	1_KEGG_FOCAL_ADHESION	0.750	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_MELANOMA	0.500	
NOS1	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	2_CELL_CELL_SIGNALING	0.667	2_SYNAPTIC_TRANSMISSION	0.667	2_TRANSMISSION_OF_NERVE_IMPULSE	0.667	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	
NOS3	9	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	2_CELL_CYCLE_GO_0007049	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	0.889	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.778	1_KEGG_PATHWAYS_IN_CANCER	0.778	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_MELANOMA	0.667	
NRXN1	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX	0.667	2_COLLAGEN	0.667	2_CELL_CELL_SIGNALING	0.667	
NTRK1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	2_REPLICATION_FORK	1.000	2_CHROMOSOME	1.000	2_DNA_METABOLIC_PROCESS	1.000	2_INTERPHASE	1.000	
NTRK3	1	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_APICAL_JUNCTION	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	0_HALLMARK_COAGULATION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	
NUMA1	3	1_KEGG_P53_SIGNALING_PATHWAY	1.000	2_CELL_CYCLE_PHASE	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	1.000	0_HALLMARK_MITOTIC_SPINDLE	0.667	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_CELL_CYCLE	0.667	
NXF1	1	
P2RX2	1	2_LIGAND_GATED_CHANNEL_ACTIVITY	1.000	
PARP1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	
PCDH11X	6	
PCDH11Y	61	
PCDH15	9	2_MICROVILLUS	0.333	2_PHOTORECEPTOR_CELL_MAINTENANCE	0.333	
PCDH19	6	
PCDH24	1	
PCDH7	4	
PCDH9	5	2_MICROVILLUS	0.200	2_PHOTORECEPTOR_CELL_MAINTENANCE	0.200	
PCDHA8	4	
PCDHA9	8	
PCDHAC2	33	0_HALLMARK_G2M_CHECKPOINT	0.030	0_HALLMARK_E2F_TARGETS	0.030	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.030	1_KEGG_CELL_CYCLE	0.030	1_KEGG_P53_SIGNALING_PATHWAY	0.030	1_KEGG_FOCAL_ADHESION	0.030	1_KEGG_ECM_RECEPTOR_INTERACTION	0.030	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	0.030	1_KEGG_PATHWAYS_IN_CANCER	0.030	
PCDHB13	4	
PCDHB2	1	
PCDHB4	2	
PCDHB5	1	
PCDHB6	2	
PCDHB7	5	
PCDHGC5	35	2_MICROVILLUS	0.057	2_PHOTORECEPTOR_CELL_MAINTENANCE	0.057	
PCM1	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	
PDGFD	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_REGION	0.500	2_EXTRACELLULAR_REGION_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	
PDGFRA	18	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.833	1_KEGG_FOCAL_ADHESION	0.833	1_KEGG_ECM_RECEPTOR_INTERACTION	0.722	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_MELANOMA	0.611	0_HALLMARK_G2M_CHECKPOINT	0.556	1_KEGG_PATHWAYS_IN_CANCER	0.556	1_KEGG_P53_SIGNALING_PATHWAY	0.500	2_CELL_CYCLE_GO_0007049	0.444	
PDGFRB	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	2_CELL_CYCLE_GO_0007049	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	
PGR	5	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_CELL_CYCLE	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	2_NON_MEMBRANE_BOUND_ORGANELLE	0.800	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.800	2_DNA_REPLICATION	0.800	
PIK3C2B	17	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.824	1_KEGG_ECM_RECEPTOR_INTERACTION	0.706	1_KEGG_FOCAL_ADHESION	0.647	0_HALLMARK_E2F_TARGETS	0.529	1_KEGG_CELL_CYCLE	0.529	0_HALLMARK_G2M_CHECKPOINT	0.471	0_HALLMARK_ANGIOGENESIS	0.471	1_KEGG_P53_SIGNALING_PATHWAY	0.471	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.471	2_EXTRACELLULAR_MATRIX	0.471	
PIK3C2G	9	1_KEGG_CELL_CYCLE	0.778	2_GABA_RECEPTOR_ACTIVITY	0.778	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.556	1_KEGG_ECM_RECEPTOR_INTERACTION	0.556	2_CELL_CELL_SIGNALING	0.556	2_SYNAPTIC_TRANSMISSION	0.556	2_TRANSMISSION_OF_NERVE_IMPULSE	0.556	0_HALLMARK_G2M_CHECKPOINT	0.444	1_KEGG_P53_SIGNALING_PATHWAY	0.444	
PIK3CA	30	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.867	1_KEGG_FOCAL_ADHESION	0.700	2_GABA_RECEPTOR_ACTIVITY	0.700	1_KEGG_CELL_CYCLE	0.667	0_HALLMARK_E2F_TARGETS	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	0_HALLMARK_G2M_CHECKPOINT	0.500	2_EXTRACELLULAR_MATRIX_PART	0.433	0_HALLMARK_ANGIOGENESIS	0.400	1_KEGG_P53_SIGNALING_PATHWAY	0.400	
PIK3CB	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	2_COLLAGEN	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.667	0_HALLMARK_E2F_TARGETS	0.667	
PIK3CD	4	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_P53_SIGNALING_PATHWAY	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	1_KEGG_MELANOMA	0.750	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.750	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	0.750	
PIK3CG	12	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.917	1_KEGG_FOCAL_ADHESION	0.833	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_CELL_CYCLE_GO_0007049	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.583	1_KEGG_MELANOMA	0.583	
PIK3R1	30	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	2_GABA_RECEPTOR_ACTIVITY	0.767	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_CELL_CYCLE	0.633	1_KEGG_ECM_RECEPTOR_INTERACTION	0.633	0_HALLMARK_E2F_TARGETS	0.567	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_UV_RESPONSE_DN	0.467	1_KEGG_P53_SIGNALING_PATHWAY	0.467	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.467	
PIK3R5	1	
PIM1	2	0_HALLMARK_MITOTIC_SPINDLE	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	2_ORGANELLE_PART	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CYTOSKELETAL_PART	0.500	
PIP5K1C	1	
PLAT	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_REGULATION_OF_ACTIN_CYTOSKELETON	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
PLAU	7	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.857	1_KEGG_P53_SIGNALING_PATHWAY	0.857	1_KEGG_FOCAL_ADHESION	0.857	1_KEGG_ECM_RECEPTOR_INTERACTION	0.714	1_KEGG_PATHWAYS_IN_CANCER	0.714	2_NON_MEMBRANE_BOUND_ORGANELLE	0.714	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.714	
PLCB1	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_REGION_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	
PLCG1	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	1_KEGG_ASTHMA	0.500	1_KEGG_ALLOGRAFT_REJECTION	0.500	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	
PLCG2	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_P53_PATHWAY	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.333	
PLCZ1	1	1_KEGG_INOSITOL_PHOSPHATE_METABOLISM	1.000	
PLG	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	2_CELL_CELL_SIGNALING	1.000	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.667	2_SYNAPTIC_TRANSMISSION	0.667	2_TRANSMISSION_OF_NERVE_IMPULSE	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	
POLA1	1	1_KEGG_DNA_REPLICATION	1.000	2_REPLICATION_FORK	1.000	
POLR2A	2	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_P53_PATHWAY	0.500	
POU2F1	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_APICAL_JUNCTION	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_COAGULATION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	0.500	
PPARA	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_MELANOMA	0.667	1_KEGG_BLADDER_CANCER	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_OOCYTE_MEIOSIS	0.333	
PPARG	1	
PPIA	6	0_HALLMARK_E2F_TARGETS	0.833	1_KEGG_CELL_CYCLE	0.833	0_HALLMARK_G2M_CHECKPOINT	0.667	2_CELL_CYCLE_GO_0007049	0.667	2_REGULATION_OF_CELL_CYCLE	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_MYC_TARGETS_V1	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_NUCLEUS	0.500	
PPP1CC	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_OOCYTE_MEIOSIS	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	
PPP1R1A	1	
PPP2R1B	1	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	1.000	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_INFLAMMATORY_RESPONSE	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	0_HALLMARK_COAGULATION	1.000	
PPP2R5D	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOMAL_PART	1.000	2_CHROMOSOME	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	
PPP3CB	6	0_HALLMARK_G2M_CHECKPOINT	0.167	0_HALLMARK_E2F_TARGETS	0.167	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.167	1_KEGG_CELL_CYCLE	0.167	2_AXON	0.167	2_MICROTUBULE_CYTOSKELETON	0.167	2_NON_MEMBRANE_BOUND_ORGANELLE	0.167	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.167	2_NEURON_PROJECTION	0.167	
PPP3CC	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	
PRKACG	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	
PRKCA	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	
PRKCB	3	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_DNA_REPLICATION	0.667	2_REGULATION_OF_PHOSPHORYLATION	0.667	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	0.667	0_HALLMARK_MITOTIC_SPINDLE	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	
PRKCD	3	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	2_CELL_CYCLE_CHECKPOINT_GO_0000075	1.000	2_CELL_CYCLE_GO_0007049	1.000	2_REGULATION_OF_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_BLADDER_CANCER	0.667	
PRKCG	2	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	0.500	1_KEGG_OOCYTE_MEIOSIS	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_CELL_CELL_SIGNALING	0.500	2_SYNAPTIC_TRANSMISSION	0.500	
PRKCQ	5	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	1_KEGG_CELL_CYCLE	0.800	2_NON_MEMBRANE_BOUND_ORGANELLE	0.800	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.800	2_CHROMOSOMAL_PART	0.800	2_CHROMOSOME	0.800	2_CELL_CYCLE_GO_0007049	0.800	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.600	1_KEGG_P53_SIGNALING_PATHWAY	0.600	
PRKDC	7	0_HALLMARK_E2F_TARGETS	0.571	0_HALLMARK_G2M_CHECKPOINT	0.429	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.429	1_KEGG_CELL_CYCLE	0.429	1_KEGG_P53_SIGNALING_PATHWAY	0.429	1_KEGG_FOCAL_ADHESION	0.286	2_DNA_METABOLIC_PROCESS	0.286	2_MITOTIC_CELL_CYCLE	0.286	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.286	2_CELL_CYCLE_GO_0007049	0.286	
PRKX	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_REPLICATION_FORK	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CHROMOSOMAL_PART	1.000	
PRKY	53	2_GABA_RECEPTOR_ACTIVITY	0.453	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.396	1_KEGG_CELL_CYCLE	0.377	0_HALLMARK_E2F_TARGETS	0.321	1_KEGG_ECM_RECEPTOR_INTERACTION	0.302	0_HALLMARK_G2M_CHECKPOINT	0.245	1_KEGG_P53_SIGNALING_PATHWAY	0.245	2_COLLAGEN	0.245	2_SYNAPTIC_TRANSMISSION	0.245	0_HALLMARK_UV_RESPONSE_DN	0.226	
PSIP1	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	2_CELL_CYCLE_PROCESS	0.667	2_MITOTIC_CELL_CYCLE	0.667	2_CELL_CYCLE_PHASE	0.667	2_CELL_CYCLE_CHECKPOINT_GO_0000075	0.667	2_CELL_CYCLE_GO_0007049	0.667	2_REGULATION_OF_CELL_CYCLE	0.667	
PSMA2	5	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.800	2_CELL_CYCLE_GO_0007049	0.800	2_REGULATION_OF_CELL_CYCLE	0.800	0_HALLMARK_MYC_TARGETS_V1	0.600	2_MICROTUBULE_CYTOSKELETON	0.600	2_NON_MEMBRANE_BOUND_ORGANELLE	0.600	2_NUCLEUS	0.600	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.600	
PSMA5	1	1_KEGG_PROTEASOME	1.000	
PSMB8	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	2_CELL_CYCLE_GO_0007049	1.000	0_HALLMARK_MITOTIC_SPINDLE	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	
PSMC2	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_CELL_PROLIFERATION_GO_0008283	1.000	2_CELL_CYCLE_GO_0007049	1.000	
PSMD13	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_E2F_TARGETS	0.333	
PSMD4	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_ESTROGEN_RESPONSE_EARLY	1.000	0_HALLMARK_ESTROGEN_RESPONSE_LATE	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	2_ORGANELLE_PART	1.000	2_AXON	1.000	2_INTERMEDIATE_FILAMENT_CYTOSKELETON	1.000	
PTBP1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	
PTEN	95	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.695	1_KEGG_FOCAL_ADHESION	0.663	1_KEGG_ECM_RECEPTOR_INTERACTION	0.621	1_KEGG_CELL_CYCLE	0.558	0_HALLMARK_E2F_TARGETS	0.516	1_KEGG_P53_SIGNALING_PATHWAY	0.516	0_HALLMARK_UV_RESPONSE_DN	0.495	2_GABA_RECEPTOR_ACTIVITY	0.495	0_HALLMARK_G2M_CHECKPOINT	0.442	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.400	
PTK2B	2	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_MELANOMA	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_REGULATION_OF_PHOSPHORYLATION	0.500	
PTPN11	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	2_GABA_RECEPTOR_ACTIVITY	0.750	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_FOCAL_ADHESION	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX	0.500	2_COLLAGEN	0.500	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.500	2_RECEPTOR_ACTIVITY	0.500	
PTPN6	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	2_CELL_CELL_SIGNALING	0.667	2_SYNAPTIC_TRANSMISSION	0.667	2_TRANSMISSION_OF_NERVE_IMPULSE	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_APOPTOSIS	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_CELL_CYCLE	0.333	
PTPRB	7	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	0.857	2_EXTRACELLULAR_MATRIX_PART	0.857	0_HALLMARK_UV_RESPONSE_DN	0.714	1_KEGG_FOCAL_ADHESION	0.714	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.714	2_EXTRACELLULAR_MATRIX	0.714	2_COLLAGEN	0.714	0_HALLMARK_E2F_TARGETS	0.571	1_KEGG_CELL_CYCLE	0.571	
PTPRC	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	
PTPRM	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_MELANOMA	1.000	2_COLLAGEN	1.000	
PXN	2	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_BLADDER_CANCER	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_FOCAL_ADHESION	0.500	
RAB3GAP2	4	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	0.750	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.750	2_TRANSMISSION_OF_NERVE_IMPULSE	0.750	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.250	0_HALLMARK_ANGIOGENESIS	0.250	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.250	
RABIF	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	
RAC1	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	2_ORGANELLE_PART	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_NUCLEUS	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	
RAD21	1	0_HALLMARK_G2M_CHECKPOINT	1.000	
RAD50	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_MICROTUBULE_ASSOCIATED_COMPLEX	0.500	
RAF1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_PANCREATIC_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	
RALA	4	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_CELL_CYCLE	0.750	2_CELL_CYCLE_GO_0007049	0.750	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_MELANOMA	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_CHROMOSOME	0.500	2_CELL_PROLIFERATION_GO_0008283	0.500	
RALGDS	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	
RAN	1	1_KEGG_GLIOMA	1.000	1_KEGG_MELANOMA	1.000	1_KEGG_BLADDER_CANCER	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_NEUROLOGICAL_SYSTEM_PROCESS	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
RASA1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	
RASGRF1	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	0_HALLMARK_UV_RESPONSE_DN	0.667	0_HALLMARK_ANGIOGENESIS	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_EXTRACELLULAR_MATRIX	0.667	2_COLLAGEN	0.667	
RASSF5	1	
RB1	22	0_HALLMARK_E2F_TARGETS	0.818	1_KEGG_CELL_CYCLE	0.818	0_HALLMARK_G2M_CHECKPOINT	0.773	2_CELL_CYCLE_GO_0007049	0.682	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.636	1_KEGG_P53_SIGNALING_PATHWAY	0.636	1_KEGG_FOCAL_ADHESION	0.591	2_REGULATION_OF_CELL_CYCLE	0.591	1_KEGG_ECM_RECEPTOR_INTERACTION	0.545	2_GABA_RECEPTOR_ACTIVITY	0.545	
RBBP4	1	
RBMX	1	
RECQL	1	
RECQL5	2	2_DNA_METABOLIC_PROCESS	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	
RELN	9	1_KEGG_CELL_CYCLE	0.556	2_GABA_RECEPTOR_ACTIVITY	0.556	0_HALLMARK_E2F_TARGETS	0.444	1_KEGG_FOCAL_ADHESION	0.444	1_KEGG_ECM_RECEPTOR_INTERACTION	0.444	1_KEGG_PATHWAYS_IN_CANCER	0.444	1_KEGG_MELANOMA	0.444	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_ANGIOGENESIS	0.333	
RERE	6	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	0.667	2_EXTRACELLULAR_MATRIX_PART	0.667	2_EXTRACELLULAR_MATRIX	0.667	1_KEGG_CELL_CYCLE	0.500	1_KEGG_MELANOMA	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_APOPTOSIS	0.333	
RFC4	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_COAGULATION	0.500	
RIMS2	11	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.909	1_KEGG_FOCAL_ADHESION	0.818	1_KEGG_ECM_RECEPTOR_INTERACTION	0.818	2_COLLAGEN	0.727	2_GABA_RECEPTOR_ACTIVITY	0.727	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.636	0_HALLMARK_E2F_TARGETS	0.545	0_HALLMARK_UV_RESPONSE_DN	0.545	1_KEGG_CELL_CYCLE	0.545	2_EXTRACELLULAR_MATRIX_PART	0.545	
RNF8	2	0_HALLMARK_MITOTIC_SPINDLE	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	2_ORGANELLE_PART	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_CYTOSKELETAL_PART	0.500	
ROCK2	2	2_SYNAPTIC_TRANSMISSION	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	2_REPLICATION_FORK	0.500	2_CHROMOSOME	0.500	
RPA2	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_HOMOLOGOUS_RECOMBINATION	0.500	1_KEGG_CELL_CYCLE	0.500	2_AXON	0.500	2_MICROTUBULE_CYTOSKELETON	0.500	2_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	0.500	2_NEURON_PROJECTION	0.500	
RPN1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	1.000	
RRM2	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_MYC_TARGETS_V1	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	2_REPLICATION_FORK	0.500	2_CHROMOSOME	0.500	2_DNA_METABOLIC_PROCESS	0.500	2_INTERPHASE	0.500	
RUVBL2	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	
RYR1	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	2_GABA_RECEPTOR_ACTIVITY	0.750	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_MELANOMA	0.500	2_EXTRACELLULAR_MATRIX_PART	0.500	2_CELL_CELL_SIGNALING	0.500	2_TRANSMISSION_OF_NERVE_IMPULSE	0.500	
RYR2	17	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.412	1_KEGG_ECM_RECEPTOR_INTERACTION	0.412	2_GABA_RECEPTOR_ACTIVITY	0.412	0_HALLMARK_E2F_TARGETS	0.353	1_KEGG_FOCAL_ADHESION	0.353	2_CELL_CELL_SIGNALING	0.353	0_HALLMARK_G2M_CHECKPOINT	0.294	1_KEGG_CELL_CYCLE	0.294	2_SYNAPTIC_TRANSMISSION	0.294	1_KEGG_P53_SIGNALING_PATHWAY	0.235	
RYR3	13	1_KEGG_CALCIUM_SIGNALING_PATHWAY	0.308	2_CALCIUM_CHANNEL_ACTIVITY	0.308	2_LIGAND_GATED_CHANNEL_ACTIVITY	0.231	1_KEGG_MELANOMA	0.154	2_CATION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.154	2_SUBSTRATE_SPECIFIC_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.154	2_SUBSTRATE_SPECIFIC_TRANSPORTER_ACTIVITY	0.154	2_METAL_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.154	2_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.154	2_ION_TRANSMEMBRANE_TRANSPORTER_ACTIVITY	0.154	
S100A8	2	
SCML2	2	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_MELANOMA	0.500	1_KEGG_ASTHMA	0.500	
SDC2	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_MYC_TARGETS_V1	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_DNA_REPLICATION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	
SDCCAG8	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	1_KEGG_GLIOMA	0.500	1_KEGG_MELANOMA	0.500	
SEC61G	53	1_KEGG_CELL_CYCLE	0.377	0_HALLMARK_E2F_TARGETS	0.358	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.358	1_KEGG_ECM_RECEPTOR_INTERACTION	0.321	0_HALLMARK_G2M_CHECKPOINT	0.283	1_KEGG_P53_SIGNALING_PATHWAY	0.264	1_KEGG_FOCAL_ADHESION	0.264	2_GABA_RECEPTOR_ACTIVITY	0.264	1_KEGG_DNA_REPLICATION	0.208	0_HALLMARK_ANGIOGENESIS	0.189	
SFI1	2	
SFN	1	0_HALLMARK_HYPOXIA	1.000	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_ESTROGEN_RESPONSE_LATE	1.000	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_COAGULATION	1.000	1_KEGG_CELL_CYCLE	1.000	
SGCB	1	
SGOL1	1	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	1.000	2_AXON	1.000	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	2_NEURON_PROJECTION	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
SGOL2	3	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_COMPLEMENT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_NEUROACTIVE_LIGAND_RECEPTOR_INTERACTION	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_OOCYTE_MEIOSIS	0.333	
SH3GL3	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_COAGULATION	0.500	0_HALLMARK_ALLOGRAFT_REJECTION	0.500	0_HALLMARK_KRAS_SIGNALING_UP	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_COMPLEMENT_AND_COAGULATION_CASCADES	0.500	
SHANK3	2	
SHB	4	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	2_GABA_RECEPTOR_ACTIVITY	0.500	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_COMPLEMENT	0.250	0_HALLMARK_INFLAMMATORY_RESPONSE	0.250	0_HALLMARK_ANGIOGENESIS	0.250	
SLC18A2	6	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	2_CELL_CYCLE_GO_0007049	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	
SLC26A8	4	0_HALLMARK_MITOTIC_SPINDLE	0.500	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	2_INTERPHASE	0.500	2_CELL_CYCLE_PROCESS	0.500	2_CELL_CYCLE_PHASE	0.500	2_CELL_CYCLE_GO_0007049	0.500	0_HALLMARK_MYC_TARGETS_V1	0.250	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.250	
SLC6A3	6	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.333	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.333	1_KEGG_ASTHMA	0.333	
SLIT3	2	
SMAD4	2	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_COMPLEMENT	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_LEISHMANIA_INFECTION	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	
SMARCA2	5	0_HALLMARK_G2M_CHECKPOINT	0.800	0_HALLMARK_E2F_TARGETS	0.800	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_CELL_CYCLE	0.800	1_KEGG_P53_SIGNALING_PATHWAY	0.800	2_CELL_CYCLE_GO_0007049	0.800	1_KEGG_FOCAL_ADHESION	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	2_EXTRACELLULAR_MATRIX_PART	0.600	2_CELL_CYCLE_PROCESS	0.600	
SMARCA4	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_NEUROTROPHIN_SIGNALING_PATHWAY	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	1.000	
SMARCC2	5	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.800	1_KEGG_LEISHMANIA_INFECTION	0.800	1_KEGG_ASTHMA	0.800	1_KEGG_ALLOGRAFT_REJECTION	0.800	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	0.800	0_HALLMARK_E2F_TARGETS	0.600	0_HALLMARK_UV_RESPONSE_DN	0.600	1_KEGG_CELL_CYCLE	0.600	
SMC1A	4	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	2_DNA_METABOLIC_PROCESS	0.750	2_CELL_CYCLE_PROCESS	0.750	2_MITOTIC_CELL_CYCLE	0.750	2_CELL_CYCLE_PHASE	0.750	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.750	2_CELL_CYCLE_GO_0007049	0.750	
SMC3	5	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	2_CELL_CYCLE_GO_0007049	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	1_KEGG_PATHWAYS_IN_CANCER	0.800	1_KEGG_BLADDER_CANCER	0.800	
SMO	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_MELANOMA	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_CELL_PROLIFERATION_GO_0008283	0.667	2_CELL_CYCLE_GO_0007049	0.667	
SOS1	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_REGION	1.000	
SP1	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	
SPN	1	0_HALLMARK_APICAL_JUNCTION	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
SRC	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	
SREBF1	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_APOPTOSIS	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_COMPLEMENT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	0_HALLMARK_COAGULATION	1.000	0_HALLMARK_ALLOGRAFT_REJECTION	1.000	
SRI	5	2_CELL_CELL_SIGNALING	0.400	2_SYNAPTIC_TRANSMISSION	0.400	2_REGULATION_OF_HEART_CONTRACTION	0.400	2_NEUROLOGICAL_SYSTEM_PROCESS	0.400	2_TRANSMISSION_OF_NERVE_IMPULSE	0.400	2_SYSTEM_PROCESS	0.400	2_GABA_RECEPTOR_ACTIVITY	0.400	1_KEGG_FOCAL_ADHESION	0.200	1_KEGG_ECM_RECEPTOR_INTERACTION	0.200	2_GENERATION_OF_A_SIGNAL_INVOLVED_IN_CELL_CELL_SIGNALING	0.200	
SRPK1	3	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_MYC_TARGETS_V1	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	0_HALLMARK_ANGIOGENESIS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_ECM_RECEPTOR_INTERACTION	0.667	2_NON_MEMBRANE_BOUND_ORGANELLE	0.667	
SRPR	1	1_KEGG_PROTEIN_EXPORT	1.000	
SSRP1	1	
STAT1	2	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_ALLOGRAFT_REJECTION	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.500	
STAT3	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_INTERPHASE	1.000	2_CELL_CYCLE_PROCESS	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CYCLE_PHASE	1.000	2_CELL_CELL_SIGNALING	1.000	2_CELL_CYCLE_CHECKPOINT_GO_0000075	1.000	
STAT6	7	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.857	0_HALLMARK_E2F_TARGETS	0.714	1_KEGG_CELL_CYCLE	0.714	1_KEGG_ECM_RECEPTOR_INTERACTION	0.714	0_HALLMARK_G2M_CHECKPOINT	0.571	1_KEGG_P53_SIGNALING_PATHWAY	0.571	1_KEGG_FOCAL_ADHESION	0.571	1_KEGG_BLADDER_CANCER	0.571	2_EXTRACELLULAR_MATRIX_PART	0.571	2_CELL_CYCLE_GO_0007049	0.571	
STX1A	5	0_HALLMARK_G2M_CHECKPOINT	0.600	0_HALLMARK_E2F_TARGETS	0.600	1_KEGG_CELL_CYCLE	0.600	1_KEGG_ECM_RECEPTOR_INTERACTION	0.600	1_KEGG_MELANOMA	0.600	2_CELL_CYCLE_GO_0007049	0.600	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.400	0_HALLMARK_COMPLEMENT	0.400	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.400	0_HALLMARK_ANGIOGENESIS	0.400	
STXBP1	2	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.500	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_INFLAMMATORY_RESPONSE	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	0_HALLMARK_COAGULATION	0.500	
SVEP1	4	
SYNJ1	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	
SYNJ2	2	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	
SYT1	2	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	
TAP1	1	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_ASTHMA	1.000	1_KEGG_AUTOIMMUNE_THYROID_DISEASE	1.000	1_KEGG_ALLOGRAFT_REJECTION	1.000	1_KEGG_GRAFT_VERSUS_HOST_DISEASE	1.000	1_KEGG_VIRAL_MYOCARDITIS	1.000	2_CELL_CELL_SIGNALING	1.000	
TARDBP	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_SMALL_CELL_LUNG_CANCER	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	
TBL1Y	22	1_KEGG_CELL_CYCLE	0.818	0_HALLMARK_E2F_TARGETS	0.727	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.727	0_HALLMARK_G2M_CHECKPOINT	0.636	1_KEGG_P53_SIGNALING_PATHWAY	0.636	2_GABA_RECEPTOR_ACTIVITY	0.591	1_KEGG_ECM_RECEPTOR_INTERACTION	0.545	2_CELL_CYCLE_GO_0007049	0.545	2_REGULATION_OF_CELL_CYCLE	0.455	1_KEGG_FOCAL_ADHESION	0.409	
TCF12	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	2_GABA_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_UV_RESPONSE_DN	0.333	0_HALLMARK_ANGIOGENESIS	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_TGF_BETA_SIGNALING_PATHWAY	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.333	
TCF7L2	7	0_HALLMARK_E2F_TARGETS	0.857	1_KEGG_CELL_CYCLE	0.857	0_HALLMARK_G2M_CHECKPOINT	0.714	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.714	1_KEGG_P53_SIGNALING_PATHWAY	0.714	1_KEGG_FOCAL_ADHESION	0.714	2_CELL_CYCLE_GO_0007049	0.714	1_KEGG_ECM_RECEPTOR_INTERACTION	0.571	1_KEGG_PATHWAYS_IN_CANCER	0.571	1_KEGG_GLIOMA	0.571	
TEK	11	0_HALLMARK_E2F_TARGETS	0.727	1_KEGG_CELL_CYCLE	0.727	2_GABA_RECEPTOR_ACTIVITY	0.636	0_HALLMARK_G2M_CHECKPOINT	0.545	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.545	1_KEGG_ECM_RECEPTOR_INTERACTION	0.545	1_KEGG_P53_SIGNALING_PATHWAY	0.455	2_CELL_CYCLE_GO_0007049	0.455	0_HALLMARK_APOPTOSIS	0.364	1_KEGG_FOCAL_ADHESION	0.364	
TES	3	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.333	1_KEGG_MISMATCH_REPAIR	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_FOCAL_ADHESION	0.333	
TFAP2B	1	1_KEGG_AMYOTROPHIC_LATERAL_SCLEROSIS_ALS	1.000	2_AXON	1.000	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	2_NEURON_PROJECTION	1.000	2_CELL_CELL_SIGNALING	1.000	2_SYNAPTIC_TRANSMISSION	1.000	2_TRANSMISSION_OF_NERVE_IMPULSE	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
TGFBI	1	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_GLYCOLYSIS	1.000	0_HALLMARK_ANGIOGENESIS	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	1_KEGG_PANCREATIC_CANCER	1.000	1_KEGG_ENDOMETRIAL_CANCER	1.000	1_KEGG_GLIOMA	1.000	1_KEGG_PROSTATE_CANCER	1.000	
TGFBR1	2	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	1_KEGG_DNA_REPLICATION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	
TJP1	3	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_OOCYTE_MEIOSIS	0.333	1_KEGG_P53_SIGNALING_PATHWAY	0.333	1_KEGG_FOCAL_ADHESION	0.333	1_KEGG_ECM_RECEPTOR_INTERACTION	0.333	1_KEGG_PATHWAYS_IN_CANCER	0.333	1_KEGG_GLIOMA	0.333	
TLE2	1	
TNC	4	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	2_CELL_CYCLE_GO_0007049	1.000	0_HALLMARK_G2M_CHECKPOINT	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	1_KEGG_PATHWAYS_IN_CANCER	0.750	1_KEGG_BLADDER_CANCER	0.750	
TP53	93	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.785	0_HALLMARK_E2F_TARGETS	0.774	1_KEGG_CELL_CYCLE	0.763	1_KEGG_P53_SIGNALING_PATHWAY	0.763	0_HALLMARK_G2M_CHECKPOINT	0.677	2_CELL_CYCLE_GO_0007049	0.538	1_KEGG_FOCAL_ADHESION	0.505	1_KEGG_ECM_RECEPTOR_INTERACTION	0.505	2_GABA_RECEPTOR_ACTIVITY	0.505	2_NON_MEMBRANE_BOUND_ORGANELLE	0.462	
TPX2	1	
TRPV6	3	0_HALLMARK_G2M_CHECKPOINT	0.333	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.333	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.333	0_HALLMARK_E2F_TARGETS	0.333	0_HALLMARK_MYC_TARGETS_V1	0.333	1_KEGG_DNA_REPLICATION	0.333	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.333	1_KEGG_MISMATCH_REPAIR	0.333	1_KEGG_CELL_CYCLE	0.333	1_KEGG_FOCAL_ADHESION	0.333	
TSC2	4	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	0_HALLMARK_UV_RESPONSE_DN	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_PATHWAYS_IN_CANCER	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	2_REGULATION_OF_CYCLIN_DEPENDENT_PROTEIN_KINASE_ACTIVITY	0.500	2_CELL_CYCLE_GO_0007049	0.500	
TTN	17	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.824	1_KEGG_ECM_RECEPTOR_INTERACTION	0.706	1_KEGG_FOCAL_ADHESION	0.647	2_GABA_RECEPTOR_ACTIVITY	0.647	1_KEGG_CELL_CYCLE	0.588	2_EXTRACELLULAR_MATRIX_PART	0.588	0_HALLMARK_E2F_TARGETS	0.529	0_HALLMARK_UV_RESPONSE_DN	0.529	2_COLLAGEN	0.529	0_HALLMARK_G2M_CHECKPOINT	0.471	
TUBA3C	2	0_HALLMARK_HYPOXIA	0.500	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_GAP_JUNCTION	0.500	
TUBA4B	1	1_KEGG_PATHOGENIC_ESCHERICHIA_COLI_INFECTION	1.000	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_KINESIN_COMPLEX	1.000	2_CYTOSKELETAL_PART	1.000	
TUBG1	2	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	
TUBG2	1	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_MICROTUBULE_ASSOCIATED_COMPLEX	1.000	
TUBGCP5	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX	1.000	2_COLLAGEN	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	
TYK2	4	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	1_KEGG_CELL_CYCLE	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.250	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_P53_SIGNALING_PATHWAY	0.250	1_KEGG_FOCAL_ADHESION	0.250	1_KEGG_ECM_RECEPTOR_INTERACTION	0.250	1_KEGG_JAK_STAT_SIGNALING_PATHWAY	0.250	1_KEGG_BLADDER_CANCER	0.250	
VAMP1	2	0_HALLMARK_APOPTOSIS	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_P53_SIGNALING_PATHWAY	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	1_KEGG_LEISHMANIA_INFECTION	0.500	
VAMP3	4	0_HALLMARK_E2F_TARGETS	0.750	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_P53_SIGNALING_PATHWAY	0.750	1_KEGG_MELANOMA	0.750	2_GABA_RECEPTOR_ACTIVITY	0.750	0_HALLMARK_G2M_CHECKPOINT	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_PATHWAYS_IN_CANCER	0.500	
VAMP7	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	1_KEGG_BLADDER_CANCER	0.667	1_KEGG_SMALL_CELL_LUNG_CANCER	0.667	2_RECEPTOR_ACTIVITY	0.667	0_HALLMARK_TNFA_SIGNALING_VIA_NFKB	0.333	0_HALLMARK_HYPOXIA	0.333	0_HALLMARK_IL6_JAK_STAT3_SIGNALING	0.333	0_HALLMARK_DNA_REPAIR	0.333	0_HALLMARK_G2M_CHECKPOINT	0.333	
VASP	1	
VAV1	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	1.000	1_KEGG_ANTIGEN_PROCESSING_AND_PRESENTATION	1.000	1_KEGG_TYPE_I_DIABETES_MELLITUS	1.000	1_KEGG_MELANOMA	1.000	
VAV2	3	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	1_KEGG_FOCAL_ADHESION	0.667	1_KEGG_PATHWAYS_IN_CANCER	0.667	1_KEGG_GLIOMA	0.667	
VCAN	3	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_PROTEINACEOUS_EXTRACELLULAR_MATRIX	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	2_EXTRACELLULAR_MATRIX	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_E2F_TARGETS	0.667	1_KEGG_CELL_CYCLE	0.667	1_KEGG_P53_SIGNALING_PATHWAY	0.667	
VEGFA	4	0_HALLMARK_G2M_CHECKPOINT	0.500	0_HALLMARK_E2F_TARGETS	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_ANGIOGENESIS	0.500	1_KEGG_CELL_CYCLE	0.500	1_KEGG_FOCAL_ADHESION	0.500	1_KEGG_ECM_RECEPTOR_INTERACTION	0.500	1_KEGG_CELL_ADHESION_MOLECULES_CAMS	0.500	1_KEGG_INTESTINAL_IMMUNE_NETWORK_FOR_IGA_PRODUCTION	0.500	1_KEGG_TYPE_I_DIABETES_MELLITUS	0.500	
VLDLR	2	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	0_HALLMARK_UV_RESPONSE_DN	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	1_KEGG_MELANOMA	1.000	2_EXTRACELLULAR_MATRIX_PART	1.000	
WEE2	4	0_HALLMARK_G2M_CHECKPOINT	0.750	0_HALLMARK_E2F_TARGETS	0.750	1_KEGG_CELL_CYCLE	0.750	1_KEGG_FOCAL_ADHESION	0.750	1_KEGG_ECM_RECEPTOR_INTERACTION	0.750	2_CELL_CYCLE_GO_0007049	0.750	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.500	0_HALLMARK_COMPLEMENT	0.500	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.500	0_HALLMARK_UV_RESPONSE_DN	0.500	
XIAP	1	1_KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY	1.000	2_CASPASE_REGULATOR_ACTIVITY	1.000	
XRCC2	5	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	1_KEGG_CELL_CYCLE	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.800	1_KEGG_FOCAL_ADHESION	0.800	1_KEGG_ECM_RECEPTOR_INTERACTION	0.800	2_CELL_CYCLE_GO_0007049	0.800	0_HALLMARK_ANGIOGENESIS	0.600	1_KEGG_DNA_REPLICATION	0.600	1_KEGG_PATHWAYS_IN_CANCER	0.600	
YWHAH	1	1_KEGG_CELL_CYCLE	1.000	1_KEGG_PATHWAYS_IN_CANCER	1.000	2_REGULATION_OF_PHOSPHORYLATION	1.000	2_CELL_CELL_SIGNALING	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHORYLATION	1.000	2_NEGATIVE_REGULATION_OF_PHOSPHATE_METABOLIC_PROCESS	1.000	2_GABA_RECEPTOR_ACTIVITY	1.000	
ZNF212	4	0_HALLMARK_G2M_CHECKPOINT	0.250	0_HALLMARK_INTERFERON_ALPHA_RESPONSE	0.250	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.250	0_HALLMARK_E2F_TARGETS	0.250	0_HALLMARK_MYC_TARGETS_V1	0.250	1_KEGG_DNA_REPLICATION	0.250	1_KEGG_NUCLEOTIDE_EXCISION_REPAIR	0.250	1_KEGG_MISMATCH_REPAIR	0.250	1_KEGG_CELL_CYCLE	0.250	1_KEGG_FOCAL_ADHESION	0.250	
ZNF274	1	
ZNF3	3	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	0_HALLMARK_G2M_CHECKPOINT	0.667	0_HALLMARK_INTERFERON_GAMMA_RESPONSE	0.667	0_HALLMARK_COMPLEMENT	0.667	0_HALLMARK_E2F_TARGETS	0.667	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	0.667	0_HALLMARK_UV_RESPONSE_DN	0.667	0_HALLMARK_ANGIOGENESIS	0.667	1_KEGG_CELL_CYCLE	0.667	
ZWINT	4	0_HALLMARK_G2M_CHECKPOINT	1.000	0_HALLMARK_E2F_TARGETS	1.000	0_HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION	1.000	1_KEGG_CELL_CYCLE	1.000	1_KEGG_P53_SIGNALING_PATHWAY	1.000	1_KEGG_FOCAL_ADHESION	1.000	1_KEGG_ECM_RECEPTOR_INTERACTION	1.000	2_MICROTUBULE_CYTOSKELETON	1.000	2_NON_MEMBRANE_BOUND_ORGANELLE	1.000	2_INTRACELLULAR_NON_MEMBRANE_BOUND_ORGANELLE	1.000	
